Description

Tirzepatide 60mg For Sale — Research Peptide

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is the active ingredient in FDA-approved Mounjaro (diabetes) and Zepbound (weight management), and represents the current clinical gold standard for GLP-based metabolic research — making it an essential reference compound for laboratories studying incretin biology and next-generation metabolic peptides.

Research Profile

Phase 3 SURMOUNT trial data demonstrated average body weight reduction of approximately 20.9% at the highest dose over 72 weeks. Researchers use tirzepatide as the primary comparator compound when studying newer triple agonists such as retatrutide and cagrilintide/semaglutide combinations. The 60mg vial is the highest-concentration format available, suited for extended research protocols.